Towards Healthcare

Exoskeleton Market Investment Trends and Funding for Innovation

According to our forecasts, the global exoskeleton market was valued at USD 595.12 million in 2025 and is expected to reach USD 681.53 million in 2026, expanding to approximately USD 2,308.97 million by 2035, growing at a CAGR of 14.52% during 2026–2035.

Last Updated : 12 March 2026 Category: Medical Devices Insight Code: 6749 Format: PDF / PPT / Excel
Revenue, 2025
USD 595.12 Million
Forecast, 2035
USD 2308.97 Million
CAGR, 2026-2035
14.52%
Report Coverage
Global

The global exoskeleton market size was estimated at USD 595.12 million in 2025 and is predicted to increase from USD 681.53 million in 2026 to approximately USD 2308.97 million by 2035, expanding at a CAGR of 14.52% from 2026 to 2035.

Exoskeleton Market Size is USD 681.53 Million in 2026.

The exoskeleton market is growing, as exoskeletons in the healthcare sector are currently used principally in rehabilitation. It relieves them of physically challenging work, like in nursing or in the operating room.

Key Takeaways

  • Exoskeleton market to crossed USD 681.53 million by 2026.
  • Market projected at USD 2308.97 million by 2035.
  • CAGR of 14.52% expected in between 2026 to 2035.
  • North America dominated the exoskeleton market in 2025.
  • Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
  • By mobility, the mobile segment dominated the market in 2025.
  • By mobility, the fixed/stationary segment is expected to grow at a significant CAGR in the market during the forecast period.
  • By technology, the powered segment dominated the market in 2025.
  • By technology, the non-powered technology segment is expected to grow fastest in the market during the forecast period.
  • By extremity, the lower body segment dominated the exoskeleton market in 2025.
  • By extremity, the upper body segment is expected to grow fastest in the market during the forecast period. 
  • By end use, the healthcare segment dominated in 2025.
  • By end use, the industry segment is expected to grow fastest in the market during the forecast period.

Market Overview: What is an Exoskeleton?

The exoskeleton market is growing, as exoskeletons have broad applications in the military, medical, and construction fields. In the medical field, physical therapists use them as locomotor-assistance and gait-training tools for patients with conditions or injuries that affect mobility. There are two types of exoskeletons, powered and passive. An exoskeleton suit is a wearable tool that improves a patient's strength and performance, enabling them to complete some tasks or to rehabilitate their body. Exoskeleton is intended to offer physical support when consumers are lifting and shifting items or people, like nurses moving patients,  seniors seeking physical therapy, receiving assistance when sitting down or standing up.

How is AI governing the Exoskeleton Market?

Integration of AI-driven technology in exoskeleton drives market growth, as an AI-driven assistance technology led to a quantifiable lowering in muscle activation during physical movements, indicating that the exoskeleton was efficiently helping the consumer's body. Artificial Intelligence (AI) integration in the wearable exoskeletons is an evolving advancement in building safety. The AI-driven exoskeleton collects load, motion, and environmental information through embedded sensors.

  • Exoskeletons in Healthcare: Exoskeletons in the healthcare sector are currently used mainly in rehabilitation. Medical staff also progressively benefit from them; exoskeletons relieve them of manually demanding work.
  • Exoskeleton for the Elderly Patients: Exoskeleton for the aging people provides an advanced service to enhance physical function, improve walking rehabilitation, and empower neurological rehabilitation centers to deliver more efficient care.
  • Advanced Sensors in Exoskeleton: Increasing applications of advanced sensor technology. These sensors, substituted as the perception layer, allow real-time, high-precision identification of human movement intentions and biomechanical loads.

Key Indicators and Highlights

Table Scope
Market Size in 2026 USD 681.53 Million
Projected Market Size in 2035 USD 2308.97 Million
CAGR (2026 - 2035) 14.52%
Leading Region North America by 45%
Historical Data 2020 - 2023
Base Year 2025
Forecast Period 2026 - 2035
Measurable Values USD Millions/Units/Volume
Market Segmentation By Mobility, By Technology, By Extremity, By End Use, By Region
Top Key Players Ekso Bionics, ARMASTEC PTE. LTD, Hocoma, Lockheed Martin Corporation, Suit X, Rex Bionics Plc.

Segmentation Analysis

By Mobility Insights

Which Mobility Segment Led the Exoskeleton Market in 2025?

The mobile segment held the dominant market in 2025, due to the mobile exoskeleton providing superior freedom of movement and making daily life easier for patients with disabilities. To encourage the mobility of aging people and maintain their independence, assistive robotics services like exoskeletons could offer targeted support with movements. They offer targeted support for physical performance and lower the strain of physically demanding responsibilities.

Fixed/Stationary

Whereas the fixed/stationary segment is expected to grow at a significant rate in the market, as these exoskeletons (LLEs) have evolved as a promising service to enhance physical function in older patients. Exoskeletons lessen strain, prevent injuries, and increase endurance in physically demanding professions. The exoskeleton not only assists the power of the consumers, but it rehabilitate the patient. Stationary systems allow for a higher number of repetitions as compared to outdated manual rehabilitation.

By Technology Insights

Why did the Powered Segment Dominate the Market in 2025?

The powered segment was dominant in the exoskeleton market in 2025, as powered exoskeletons offer real-time support, allowing patients to lift heavier loads or walk longer distances with less fatigue. This makes them specifically significant for patients with mobility issues. Increasing the strength and endurance of workers performing repetitive or strenuous tasks. Powered exoskeletons allow targeted therapy by guiding particular movements, monitoring ongoing progress, and providing consistent assistance in the sessions.

Non-Powered Technology

Whereas the non-powered technology segment is the fastest-growing in the market, as Non-powered exoskeletons are potentially inexpensive to acquire and maintain compared to active exoskeletons, providing a higher return on spending for small-to-medium enterprises. They need no recharging or external power supply, enabling unlimited operational time and removing downtime. They rely on mechanical structures, like springs or pneumatic systems, to offer support or resistance.

By Extremity Insights

Why did the Lower Body Segment Dominate the Market in 2025?

The lower body segment was dominant in the exoskeleton market in 2025, as it supports the wearer’s lower limb strength, making it simple and more suitable to lift heavy objects. The tools support the waist, shoulders, and legs, promoting correct posture and supporting to prevent injuries. Exoskeletons are applicable for rehabilitation in different conditions, significantly neurological and, to a lesser extent, musculoskeletal situations. Lower extremity exoskeletons industrialized for human strength augmentation improve human strength and endurance throughout locomotion.

Upper Body

Whereas the upper body segment is the fastest-growing in the market, as upper-limb exoskeleton helps to maintain a more upright low back posture and better spinal stability. Major upper extremity exoskeletons are anthropomorphic in intended use and help the entire arm or even the whole body. It reduces the physical strain on workers by offering support, promoting ergonomic posture, and mobility.

By End Use Insights

Why did the Healthcare Segment Dominate the Market in 2025?

The healthcare segment was dominant in the exoskeleton market in 2025, as the application of exoskeletons has the strength to positively influence nurses' work life by reducing work-associated injuries, enhancing physical well-being, improving job satisfaction, and promoting psychological and psychosocial advantages. Exoskeletons play a significant role in the healthcare professions. They help to support patients in their mobility. Exoskeletons are used by patients who walk after a neurological injury, and walking is significant for both functional mobility and activity-driven therapy.

Industry

Whereas the industry segment is the fastest-growing in the market, as exoskeletons are used instead of industrial robots, and eradicate the requirement for entirely automated services. Exoskeletons supports to aging workers to continue to perform labor-intensive work. Exoskeletons help to lower fatigue and avoid injuries while lifting, carrying, pushing, pulling, and performing overhead tasks, improving outcomes in the manufacturing industry.

Regional Insights

Exoskeleton Market Shares for North America, Europe, Asia Pacific, Latin America and Middle East and Africa, 2025 (%).

Regions Share 2025 (%)
North America 45%
Europe 24%
APAC 21%
Latin America 6%
Middle East and Africa 4%

How did North America dominate the Market in 2025?

In 2025, North America dominated the exoskeleton market by 45% because it is estimated that roughly 12,500 spinal cord injuries occur in this region every year. Increasing spending in R&D for Arctic defence abilities, involving advanced satellite systems for space-driven early warning and surveillance. Ergonomics in production is to design workstations that encourage healthy work postures and maintain worker safety and comfort, which drives the growth of the market.

U.S. Market Trends

In the U.S., nearly 100 units of Wandercraft exoskeletons are in use at rehabilitation organizations and healthcare research centres in the United States. The technological innovation has played a significant role in the alteration of the medical care sector by offering devices that enhance the effectiveness of treatments, data management, and interaction between professionals and patients.  The region is a hub for major organization players, like Ekso Bionics Holdings, Inc., and Lifeward Ltd. (ReWalk).

For Instance,

  • In April 2025, Lifeward Ltd. announced the U.S. national launch of the ReWalk 7 Personal Exoskeleton, the next generation of its ground-breaking personal exoskeleton technology.

Asia Pacific: Increasing Aging Population

Asia Pacific is expected to see rapid growth in the exoskeleton market, driven by growing life expectancy and declining fertility rates, resulting in a progressively older population in the region.  Japan and South Korea are at the forefront of this trend, with some of the world’s highest median ages, which surges the demand of exoskeleton. Industrial Revolution (4IR) technologies are significant in improving industrial competitiveness and output in the Asia-Pacific, leading to high acceptance of both active and passive industrial exoskeletons.

India Market Trends

India faces the highest rehabilitation requirement in Southeast Asia. Rehabilitation research is significant to define the gap between the need and available rehabilitation solutions. India is evolving as a worldwide tech investment home powered by AI, GCCs, youth talent, and digital growth. This technology encourages research and development of digital services to address real-world challenges.

Supply Chain Analysis

R&D:

  • The Research and Development (R&D) processes for medical care exoskeletons include highly multidisciplinary strategies, integration of material science, robotics, biomechanics, and AI to create wearable tools that assist with rehabilitation or mobility.
  • Key Players: Abbott Laboratories and Canon

Manufacturing Processes:

  • The manufacturing of healthcare exoskeletons includes a multidisciplinary strategy, blending advanced materials science, biomechanical engineering, and robotics. The process ensures these wearable devices are durable, lightweight, and safe for human interaction.
  • Key Players: Philips Healthcare and Natus Medical

Patient Services:

  • Patient services, including healthcare exoskeletons, are significantly focused on rehabilitation, mobility assistance, and growing independence for patients with severe motor impairments caused by conditions such as spinal cord injuries (SCI), strokes, and neurodegenerative diseases.
  • Key Players: Siemens Healthineers and GE Healthcare

Latest Updates of Key Players in the Exoskeleton Market

Exoskeleton Market Companies are Ekso Bionics, ARMASTEC PTE. LTD, Hocoma, Lockheed Martin Corporation, Suit X

Company Headquarters Latest Update
Ekso Bionics United States Ekso Bionics is a foremost developer of exoskeleton services that amplify human potential by supporting or improving strength, endurance, and mobility across healthcare and industrial applications.
ARMASTEC PTE. LTD Singapore ArmasTec develops ground-breaking fabric-based exoskeletons intended to significantly lower physical strain and enhance workplace safety.
Hocoma United States Hocoma's robotic products are exoskeletons as they are attached to one or more human joints but are fixed to a platform.
Lockheed Martin Corporation United States Lockheed Martin continues to be recognized as a leading player in the military exoskeleton.
Suit X United States suitX focuses on passive exoskeletons for workers and a gait rehabilitation powered healthcare exoskeleton.
Rex Bionics Plc. United Kingdom Rex Bionics progresses and commercializes robotic, self-supporting exoskeletons intended for rehabilitation and patients' mobility.

SWOT Analysis

Strengths

  • Exoskeletons assist patients recovering from injuries or living with mobility issues. These tools offer guided motion, supporting muscles rebuild strength. They also provide hope to patients with spinal cord injuries, allowing them to stand or walk again.
  • Exoskeletons lower the physical burden on workers. This enhances effectiveness and enables tasks to be completed rapidly.

Weakness

  • Exoskeletons are expensive, limiting their obtainability and accessibility in medical care settings, specifically in resource-constrained surroundings.

Opportunities

  • Scientists are gradually focusing on evolving exoskeletons for particular areas of the human body, consequently making the device cost-effective and less complex.
  • Exoskeleton robots are evolving as a transformative process in medical care and rehabilitation, with massive potential to enhance and restore gait capability.

Threats

  • Major challenges associated with exoskeleton is the increased chances of falling, as these tools shift a user's center of gravity and lower their ability to recover balance.
  • Long term applications of the devices cause pressure injuries, compressed nerves, and skin irritation or chafing from straps.

Recent Developments in the Exoskeleton Market

  • In February 2026, Lifeward Ltd. announced it has entered into a definitive agreement to acquire some technology assets and related know-how, including functional prototypes from Skelable Ltd., the creator of a robotic upper body orthotic tools with AI-based capabilities, for entire consideration of $480,000 in Lifeward equity, payable in installments upon the attainment of specified milestones, and a nominal cash payment at closing.
  • In May 2025, BTL, a Czech healthcare technology producer, acquired the Italian start-up U&O, which specializes in the advancement and manufacturing of exoskeletons. U&O presently produces around 50 exoskeletons yearly for patients with spinal cord damage.

Segments Covered in the Report

By Mobility

  • Mobile
  • Fixed/Stationary

By Technology

  • Powered
    • Upper Body
    • Lower Body
    • Full Body
  • Non-powered
    • Upper Body
    • Lower Body
    • Full Body

By Extremity

  • Upper Body
  • Lower Body
  • Full Body

By End Use

  • Healthcare
  • Military
  • Industry

By Region

  • North America
    • U.S.
    • Canada 
    • Mexico 
    • Rest of North America
  • Latin America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe 
    • Western Europe 
      • Germany 
      • Italy
      • France
      • Netherlands
      • Spain
      • Portugal 
      • Belgium
      • Ireland
      • UK 
      • Iceland 
      • Switzerland
      • Poland
      • Rest of Western Europe
    • Eastern Europe 
      • Austria
      • Russia & Belarus 
      • Türkiye
      • Albania 
      • Rest of Eastern Europe 
  • Asia Pacific
    • China 
    • Taiwan
    • India 
    • Japan 
    • Australia and New Zealand
    • ASEAN Countries (Singapore, Malaysia)
    • South Korea 
    • Rest of APAC 
  • MEA 
    • GCC Countries
      • Saudi Arabia 
      • United Arab Emirates (UAE)
      • Qatar 
      • Kuwait 
      • Oman 
      • Bahrain 
    • South Africa
    • Egypt 
    • Rest of MEA

FAQ's

Finding : The exoskeleton market stands at USD 681.53 million in 2026 and is expected to reach USD 2308.97 million by 2035, growing at a CAGR of 14.52% from 2026 to 2035.

Finding : North America was dominant in the market by 45% due to increasing demand for healthcare and rehabilitation, and increasing research and innovation.

Finding : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

Tags

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Related Reports

Exoskeleton Market
Updated Date: 12 March 2026   |   Report Code: 6749
WhatsApp